Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies

Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies

<b>Background/Objectives</b>: Diabetes mellitus is a growing global health concern, driving the exploration of new therapies like cannabidiol (CBD), which shows potential in improving insulin sensitivity and glycemic control, though its effects on glucose metabolism remain unclear. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Rafailovska, Elona Xhemaili, Zorica Naumovska, Olga Gigopulu, Biljana Miova, Ljubica Suturkova, Gjoshe Stefkov
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
cannabidiol
diabetes mellitus
insulin sensitivity
hepatic carbohydrate metabolism
laboratory animals
OGTT
Online Access:https://www.mdpi.com/1424-8247/18/4/446
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/4/446

Similar Items